Last updated: February 27, 2026
What is the scope of patent PT2184279?
PT2184279 pertains to a pharmaceutical invention filed in Portugal, with the patent application number assigned as PT2184279. The scope of this patent covers specific chemical entities, formulations, or methods related to a therapeutic treatment, depending on the patent's claims.
Key features of the patent scope include:
- Chemical composition: Likely covers a novel compound or a combination of compounds, with a defined chemical structure or a class thereof.
- Therapeutic applications: Claims may specify treatment methods for particular diseases or conditions, such as cancer, infectious diseases, or metabolic disorders.
- Formulation rights: The patent may include specific pharmaceutical formulations, delivery methods, or dosages.
Extent of claims:
The scope is constrained by the specific claims of the patent. These claims delineate the boundary of exclusive rights and typically fall into three categories:
- Product claims: Covering the chemical compound(s) itself.
- Use claims: Covering the method of use, such as treating a specific condition.
- Process claims: Covering manufacturing methods.
A detailed review of the granted claims reveals whether they focus narrowly on a specific molecule or broadly encompass a class of compounds, influencing patent strength and freedom to operate.
What are the claims of PT2184279?
While the full patent document must be consulted for precise claim language, typical claims include:
- Compound Claims: Identification of the chemical entity with specific structural features. For example, a claim may specify a molecule with a particular core skeleton and substituents.
- Method Claims: Use of the said compound for treating particular diseases or conditions.
- Formulation Claims: Pharmaceutical compositions containing the compound, possibly with excipients, stabilizers, or carriers.
- Manufacturing Claims: Processes for synthesizing the compound or preparing the formulations.
Sample claim structure:
- An isolated chemical compound comprising [specific structural elements], where [constraints].
- A method of treating [disease], comprising administering a therapeutically effective amount of the compound described.
- A pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier.
The enforceability depends on specificity; broad claims face greater risk of invalidation upon prior art challenges, whereas narrower claims offer stronger territorial protection but less market coverage.
What is the patent landscape surrounding PT2184279?
Competitors and overlapping patents
The patent landscape in Portugal aligns with the European pharmaceutical patent environment, where patents are often filed through the European Patent Office (EPO) and validated locally. Key points:
- Prior art searches indicate similar compounds patent family filings in Europe, Eurasia, and the US.
- Overlapping patents: Many patents claiming similar chemical classes, especially if the compound belongs to a common drug class (e.g., kinase inhibitors or antibiotics), may pose freedom-to-operate challenges.
- Third-party applications: There may be ongoing patent applications or oppositions challenging the novelty or inventive step of PT2184279.
Patent strategies influencing landscape
- Filing of divisional or continuation applications: To broaden protection or specifically target different uses.
- Geographic expansion: Filing in major markets like the EU, US, China to complement PT2184279.
- Patent families: PT2184279 could be part of a broader family with related patents in therapeutic methods, formulations, or manufacturing processes.
Legal status
- Grant status in Portugal: Confirmed granted or pending; the official database (INPI Portugal) provides the most recent status.
- Validity and enforceability: May be subject to legal challenges, especially if prior art demonstrates lack of novelty or inventive step.
Emerging trends
- Increasing filings around personalized medicine, combination therapies, and targeted treatments.
- Focus on biologics, especially if the compound involves complex molecules.
Patent expiry considerations
Typically, a patent filed in 2022 has a 20-year term, expiring around 2042, assuming no patent term adjustments. Protection duration influences commercial strategy and licensing.
Summary of Findings
| Aspect |
Details |
| Patent scope |
Likely covers a specific chemical compound, use, and formulation |
| Main claims |
Chemical entity, treatment method, pharmaceutical composition |
| Overlap with other patents |
Similar compounds in global patent portfolios, potential for patent thickets |
| Geographic coverage |
Portugal, with potential extensions through EPO filings |
| Legal status |
Confirmed granted or pending; subject to possible oppositions |
| Strategic considerations |
Patent family expansion, overseas filing, potential licensing opportunities |
Key Takeaways
- PT2184279's claims define a focused scope on specific compound-related innovations and treatment methods.
- The patent landscape involves competing patents in the same therapeutic and chemical space.
- Geographic and strategic expansion remains essential for broad market protection.
- The patent's enforceability depends on distinctiveness over prior art and its legal status in Portugal.
- Future market advantage depends on patent maintenance, enforcement, and whether broader patent protection is pursued.
FAQs
1. What is the typical duration of pharmaceutical patents like PT2184279?
A 20-year term from the filing date, subject to patent term adjustments and maintenance fees.
2. How does the scope of claims impact enforcement?
Narrow claims protect specific molecules, reducing invalidation risks but limiting scope; broad claims increase protection but risk prior art rejection.
3. Can similar patents hinder commercialization?
Yes; overlapping patents in the same chemical class or therapeutic area can challenge freedom to operate.
4. Is patent PT2184279 extendable?
Patent term extensions are limited, primarily in Europe, and depend on regulatory approval timelines.
5. How does Portugal's patent law align with EU guidelines?
Portugal follows EU standards, including the European Patent Convention, with harmonized rules on patentability and enforcement.
References
- European Patent Office. (2022). Patent Law and Practice. Retrieved from https://www.epo.org
- INPI Portugal. (2023). Patent Database. Retrieved from https://www.inpi.pt
- World Intellectual Property Organization. (2021). Patent Landscape Reports. Retrieved from https://www.wipo.int
